Insider · CIK 0002023439
Ahmet Tezel
Files at LIVN (LivaNova PLC). First filing Aug 13, 2026, latest Aug 13, 2026.
In brief
Ahmet Tezel files SEC Form 4 as officer at LIVN (LivaNova PLC). Since Aug 13, 2026, Ahmet Tezel has reported 0 open-market buys worth $0 and 1 open-market sell worth $208k, the latest filed on Aug 13, 2026.
A track record needs three past buys with six months of prices behind them; Ahmet Tezel has 0, so none is measured yet.
The newest scored trade: sold $208k of LIVN on Aug 11, 2026, filed Aug 13, 2026, scored 22 (weak). In the last 12 months: 0 buys worth $0 and 1 sell worth $208k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
LIVN: LivaNova PLC
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 22Weak | LIVNsell LivaNova PLC | $208k 2,675 shares | -31% | +59% from low-8% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Aug 11, 2026 | LIVN LivaNova PLC | 2,675 0.00% of outstanding | $210k | Aug 11, 2026 | none |
Transactions
Every row this insider has filed, 28 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 11, 2026 | LIVN LivaNova PLC | MOption exercise Ordinary Shares | +12,692 | $52.68 | $669k | 18,782 | Aug 13, 2026 |
| Aug 11, 2026 | LIVN LivaNova PLC | DDisposition to issuer Ordinary Shares | -8,589 | $77.86 | $669k | 10,193 | Aug 13, 2026 |
| Aug 11, 2026 | LIVN LivaNova PLC | FTax withholding Ordinary Shares | -1,428 | $77.86 | $111k | 8,765 | Aug 13, 2026 |
| Aug 11, 2026 | LIVN LivaNova PLC | SOpen-market sale Ordinary Shares | -2,675 | $77.74 | $208k | 6,090 | Aug 13, 2026 |
| Aug 11, 2026 | LIVN LivaNova PLC | MOption exercise Stock Appreciation Rightsderivative | -12,692 | $0.00 | $0 | 12,691 | Aug 13, 2026 |
| Jun 15, 2026 | LIVN LivaNova PLC | MOption exercise Ordinary Shares | +2,965 | $0.00 | $0 | 7,122 | Jun 17, 2026 |
| Jun 15, 2026 | LIVN LivaNova PLC | FTax withholding Ordinary Shares | -1,032 | $79.70 | $82k | 6,090 | Jun 17, 2026 |
| Jun 15, 2026 | LIVN LivaNova PLC | MOption exercise Restricted Stock Unitsderivative | -2,965 | $0.00 | $0 | 5,931 | Jun 17, 2026 |
| Mar 30, 2026 | LIVN LivaNova PLC | MOption exercise Ordinary Shares | +3,408 | $0.00 | $0 | 5,343 | Apr 1, 2026 |
| Mar 30, 2026 | LIVN LivaNova PLC | FTax withholding Ordinary Shares | -1,186 | $61.27 | $73k | 4,157 | Apr 1, 2026 |
| Mar 30, 2026 | LIVN LivaNova PLC | MOption exercise Restricted Stock Unitsderivative | -3,408 | $0.00 | $0 | 6,814 | Apr 1, 2026 |
| Mar 30, 2026 | LIVN LivaNova PLC | AGrant or award Restricted Stock Unitsderivative | +13,873 | $0.00 | $0 | 13,873 | Apr 1, 2026 |
| Mar 30, 2026 | LIVN LivaNova PLC | AGrant or award Performance Stock Unitsderivative | +4,624 | $0.00 | $0 | 4,624 | Apr 1, 2026 |
| Mar 30, 2026 | LIVN LivaNova PLC | AGrant or award Performance Stock Unitsderivative | +4,624 | $0.00 | $0 | 4,624 | Apr 1, 2026 |
| Mar 30, 2026 | LIVN LivaNova PLC | AGrant or award Performance Stock Unitsderivative | +4,624 | $0.00 | $0 | 4,624 | Apr 1, 2026 |
| Jun 15, 2025 | LIVN LivaNova PLC | MOption exercise Ordinary Shares | +2,967 | $0.00 | $0 | 2,967 | Jun 17, 2025 |
| Jun 15, 2025 | LIVN LivaNova PLC | FTax withholding Ordinary Shares | -1,032 | $45.76 | $47k | 1,935 | Jun 17, 2025 |
| Jun 15, 2025 | LIVN LivaNova PLC | MOption exercise Restricted Stock Unitsderivative | -2,967 | $0.00 | $0 | 8,896 | Jun 17, 2025 |
| Mar 30, 2025 | LIVN LivaNova PLC | AGrant or award Restricted Stock Unitsderivative | +10,222 | $0.00 | $0 | 10,222 | Apr 1, 2025 |
| Mar 30, 2025 | LIVN LivaNova PLC | AGrant or award Performance Stock Unitsderivative | +5,111 | $0.00 | $0 | 5,111 | Apr 1, 2025 |
| Mar 30, 2025 | LIVN LivaNova PLC | AGrant or award Performance Stock Unitsderivative | +5,111 | $0.00 | $0 | 5,111 | Apr 1, 2025 |
| Mar 30, 2025 | LIVN LivaNova PLC | AGrant or award Performance Stock Unitsderivative | +10,222 | $0.00 | $0 | 10,222 | Apr 1, 2025 |
| Mar 30, 2025 | LIVN LivaNova PLC | AGrant or award Stock Appreciation Rightsderivative | +22,378 | $0.00 | $0 | 22,378 | Apr 1, 2025 |
| Jun 15, 2024 | LIVN LivaNova PLC | AGrant or award Restricted Stock Unitsderivative | +11,863 | $0.00 | $0 | 11,863 | Jun 18, 2024 |
| Jun 15, 2024 | LIVN LivaNova PLC | AGrant or award Performance Stock Unitsderivative | +3,559 | $0.00 | $0 | 3,559 | Jun 18, 2024 |
| Jun 15, 2024 | LIVN LivaNova PLC | AGrant or award Performance Stock Unitsderivative | +3,559 | $0.00 | $0 | 3,559 | Jun 18, 2024 |
| Jun 15, 2024 | LIVN LivaNova PLC | AGrant or award Performance Stock Unitsderivative | +7,118 | $0.00 | $0 | 7,118 | Jun 18, 2024 |
| Jun 15, 2024 | LIVN LivaNova PLC | AGrant or award Stock Appreciation Rightsderivative | +25,383 | $0.00 | $0 | 25,383 | Jun 18, 2024 |
Questions about Ahmet Tezel
Answered from the filings on this page, as of the latest one.
Is Ahmet Tezel buying or selling?
In the last 12 months Ahmet Tezel reported 0 open-market buys worth $0 and 1 open-market sell worth $208k on SEC Form 4; the latest was sold $208k of LIVN on Aug 11, 2026. Grants, option exercises and tax withholding are not counted.
How did Ahmet Tezel's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Ahmet Tezel has 0.
Where does Ahmet Tezel file Form 4?
Ahmet Tezel has filed Form 4 at LIVN (LivaNova PLC) as Chief Innovation Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.